-
[51] Lutgendorf SK, Andersen BL. Biobehavioral approaches to cancer progression and survival: Mechanisms and interventions. Am Psychol (2015) 70:186–197
-
[52] Madhyastha S, Somayaji SN, Rao MS, et al. Hippocampal brain amines in methotrexate-induced learning and memory deficit. Can J Physiol Pharmacol (2002) 80:1076-1084
-
[53] Maier SF, Watkins LR: Immune-to-central nervous system communication and its role in modulating pain and cognition: implications for cancer and cancer treatment. Brain Behav Immun (2003) 17:125-131
-
[54] Manderbacka, K, Arffman, M, Suvisaari, J, Ahlgren-Rimpilainen, A, Lumme, S, Keskimaki, I, Pukkala, E. Effect of stage, comorbidities and treatment on survival among cancer patients with or without mental illness. Br. J. Psychiatry (2017) 211 (5), 304–309
-
[55] Meyers CA: Mood and cognitive disorders in cancer patients receiving cytokine therapy. Adv Exp Med Biol (1999) 461:75-81
-
[56] Mihaela Aldea, Lucian Craciun, Ciprian Tomuleasa, Carmen Crivii. The role of depression and neuroimmune axis in prognosis of cancer patients. JBUON (2014) 19(1): 5-14
-
[57] Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry (2009) 65:732–41; doi: 10.1016/j.biopsych.2008.11.029
-
[58] Mitchell AJ, Chan M, Bhatti H et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: A meta-analysis of interview-based studies. Lancet Oncol (2011) 12:160–174
-
[59] Myrskyla M, Kohler HP, Billari FC. Advances in development reverse fertility declines. Nature (2009) 460: 741–43
-
[60] Olufadewa II, Adesina MA, Ayorinde T. From Africa to the World: Reimagining Africa’s research capacity and culture in the global knowledge economy. Journal of Global Health (2020) 10(1)